New advances in the treatment of stroke-related insomnia
10.19845/j.cnki.zfysjjbzz.2023.0205
- VernacularTitle:脑卒中相关失眠的治疗新进展
- Author:
Yuhang LIU
1
;
Changjun SU
1
Author Information
1. Yan an University, Yan an 716000, China
- Publication Type:Journal Article
- Keywords:
Insomnia;
Stroke
- From:
Journal of Apoplexy and Nervous Diseases
2023;40(10):946-950
- CountryChina
- Language:Chinese
-
Abstract:
The treatment of insomnia currently involves drug and non-drug therapies, with varying treatment outcomes. There is no consensus on the treatment option for insomnia in patients in different post-stroke phases. This article provides a detailed literature review of common insomnia treatment methods based on their application in insomnia in the acute phase, subacute phase, and recovery phase following stroke, aiming to provide guidance for the treatment of post-stroke insomnia. Currently, there is a lack of high-quality randomized controlled trials on the treatment of stroke-related insomnia. Existing research does not support the use of benzodiazepine drugs for the treatment of stroke-related insomnia. Studies suggest that sleep hygiene education and cognitive behavioral therapy for insomnia, non-benzodiazepine drugs, melatonin receptor agonists, antihistamine H1 receptor medications, certain sedative antidepressants, orexin receptor antagonists, and traditional Chinese medicine therapy can improve sleep quality in the subacute and recovery phases after stroke, facilitating the recovery of neurological function in patients. However, there is insufficient evaluation of the impact on neurological function recovery and the side effects.
- Full text:2024061322163467633脑卒中相关失眠的治疗新进展.pdf
